Related Experiment Video
Updated: Aug 5, 2026

Workflow and Framework for Collecting and Implementing Point-of-Care Ultrasound Data in the Management of Heart Failure Patients
Published on: July 12, 2024
A high-value, cross-continuum approach to heart failure: A narrative review
Archit V Potharazu1, Alexandra I Mansour1, Scott Berkowitz2
1Johns Hopkins Medicine, Baltimore, MD, USA.
Insights
High-value heart failure management focuses on lifestyle changes and coordinated care across all stages. This approach aims to reduce healthcare costs and improve patient outcomes through integrated, longitudinal strategies.
Area of Science:
- Cardiology
- Health Services Research
- Public Health
Background:
- Heart failure (HF) is a major driver of U.S. healthcare costs, with increasing prevalence.
- HF management is well-suited for high-value care models emphasizing risk factor modification and care coordination.
- Current care models face challenges from fragmented payment and episodic outcome measurement.
Purpose of the Study:
- To review evidence supporting high-value practices in heart failure management.
- To propose an optimal cross-continuum heart failure care model.
Main Methods:
- Literature review consolidating evidence for high-value heart failure practices.
- Development of a proposed integrated care model spanning all HF stages.
Main Results:
- Stage A/B HF management: lifestyle changes, risk factor treatment, guideline-directed medical therapy (GDMT), and early specialty care.
- Stage C HF management: comprehensive care, evidence-based GDMT, and early identification of Stage D.
- Stage D HF management: palliative care and advanced HF referrals to clarify prognosis and reduce costs.
Conclusions:
- A high-value care philosophy is essential for future interdisciplinary, integrated, and longitudinal HF care.
- Shifting focus from end-stage outcomes (e.g., readmissions) to cross-continuum integration metrics is beneficial.
- Implementing a coordinated, high-value model can optimize HF patient care and resource utilization.
Abstract:
Heart failure is a leading cause of healthcare expenditure in the United States (U.S.), with both costs and prevalence expected to increase. Heart failure is uniquely suited to high-value practices that incentivize longitudinal risk-factor modification and care coordination. The objective of this review is to consolidate evidence for high-value practices in heart failure management and propose an ideal cross-continuum heart failure care model. High-value management of patients with stage A and B heart failure includes lifestyle modifications, risk factor identification and treatment, and select guideline-directed medical therapy (GDMT), with early integration of ambulatory specialty care. Patients with symptomatic (stage C) heart failure benefit from wraparound care, implementation of evidence-based GDMT, and early identification of stage D heart failure. Palliative care and advanced heart failure referrals clarify trajectory and avoid excessive cost. Although fragmented payment models and episodic outcome measurements represent barriers, an emphasis on a high-value care delivery philosophy will help health systems of tomorrow provide interdisciplinary, integrated, and longitudinal heart failure care. Systems may benefit from moving beyond end-stage outcomes, such as readmissions, to identifying metrics valuing cross-continuum integration.
Related Concept Videos
Heart Failure II: Pathophysiology
Heart Failure I: Introduction
Heart Failure V: Medical Management
Heart Failure VII: Nursing Interventions
Pathophysiology of Heart Failure
Heart Failure III: Clinical Manifestations